0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-35.05%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-57.37%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
No Data
No Data available this quarter, please select a different quarter.
-12840.57%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-10932.16%
Negative net income growth while 0458.HK stands at 0.75%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-11650.00%
Negative EPS growth while 0458.HK is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-11650.00%
Negative diluted EPS growth while 0458.HK is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.05%
Share reduction while 0458.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-145.25%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-147.96%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-88.24%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-90.44%
Negative 5Y CAGR while 0458.HK stands at 36.07%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-86.96%
Negative 3Y CAGR while 0458.HK stands at 24.99%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-124.41%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
81.82%
5Y OCF/share CAGR is similar to 0458.HK's 80.26%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
-118.11%
Negative 3Y OCF/share CAGR while 0458.HK stands at 85.26%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-162.72%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-217.56%
Negative 5Y net income/share CAGR while 0458.HK is 67.67%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-335.11%
Negative 3Y CAGR while 0458.HK is 60.10%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
20.43%
Positive growth while 0458.HK is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
-6.22%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-2.73%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-100.00%
Negative 5Y dividend/share CAGR while 0458.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-43.19%
Firm’s AR is declining while 0458.HK shows 10.08%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-48.62%
Inventory is declining while 0458.HK stands at 35.58%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-15.40%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-3.86%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-23.89%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Our R&D shrinks while 0458.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-12.52%
We cut SG&A while 0458.HK invests at 3.73%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.